The BioCardia cardiac stem cell BioAMP trial is a Phase III study looking at the efficacy of using stem cells to improve heart function in heart failure patients. It is the first trial for this technology to reach Phase II trial.

The BioCardia cardiac stem cell BioAMP trial is a Phase III study looking at the efficacy of using stem cells to improve heart function in heart failure patients. It is the first trial for this technology to reach Phase II trial.

Feature | Stem Cell Therapies | May 11, 2021 | By Simon H. Stertzer, M.D.
Is Cardiac Cell Therapy Worth Another Look?
Heart failure remains an unheralded global pandemic, costing society billions of dollars each year.[1,2] Projections...
read more
The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE) have joined the International Contrast Ultrasound Society (ICUS) in recognizing the relatively low risk and important clinical benefits of ultrasound contrast agents (UCAs), which are used routinely around the world to help detect heart disease, stratify the risk of heart attack or stroke, identify and characterize tumors throughout the abdomen, and monitor the effectiveness of cancer therapies in adul
News | Contrast Media | May 11, 2021
Medical Societies Support Safety and Benefits of Ultrasound Contrast Agents
May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (...
read more
Patients hospitalized with COVID-19 may be at risk of developing heart failure even if they do not have a previous history of heart disease or cardiovascular risk factors, a new Mount Sinai study shows. 

Getty Images

News | Heart Failure | May 11, 2021
Patients Hospitalized With COVID-19 Have a Small Risk of Heart Failure
May 11, 2021 — Patients hospitalized with COVID-19 may be at risk of developing heart failure even if they do not have...
read more
Videos | Structural Heart | May 10, 2021
VIDEO: VARC-3 Helps Standardize Structural Heart Taxonomy and Research
Philippe Géneréux, M.D., director of the structural heart program at Atlantic Health System’s Morristown Medical Center...
read more
The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health. #wearables

The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health. 

News | Wearables | May 10, 2021
Vendors and ACC Collaborate With Consumer Technology Association to Help Clinicians and Patients Understand Cardiovascular Devices
May 10, 2021 – Today, the Consumer Technology Association (CTA) announced it is collaborating with the American College...
read more
The Eko digital stethoscope can record heart soubnds and use an artificial intelligence  (AI) analysis algorithm to detect heart murmurs. I new study in the JAHA showed it has comparable performance to that of an expert cardiologist. Eko Digital Stethoscope AI Analysis Algorithm Validated in JAHA article for Detecting Heart Murmurs

The Eko digital stethoscope can record heart soubnds and use an artificial intelligence  (AI) analysis algorithm to detect heart murmurs. I new study in the JAHA showed it has comparable performance to that of an expert cardiologist.

News | Artificial Intelligence | May 10, 2021
Eko Digital Stethoscope AI Analysis Algorithm Validated for Detecting Heart Murmurs
May 10, 2021 — Eko announced the peer-reviewed publication of a clinical study that found that the Eko artificial...
read more
Videos | Radial Access | May 06, 2021
VIDEO: Radial Hemostasis Reduced by 50 Percent With StatSeal in Combination With TR Band
Arnold Seto, M.D., MPA, FSCAI, chief of cardiology, Long Beach Veterans Affairs Medical Center and director,...
read more
Videos | Coronavirus (COVID-19) | May 06, 2021
VIDEO: The Impact of COVID-19 on Heart Attack Patients
Payam Dehghani, M.D.,  FRCPC, FACC, FSCAI, co-director of Prairie Vascular Research and associate professor at the...
read more
An example of a patch type cardiac monitor from Vital Connect. These types of inexpensive, stick-on wearable monitors have seen a tremendous increase in use over the past few years, replacing traditional Holter monitors.

An example of a patch type cardiac monitor from Vital Connect. These types of inexpensive, stick-on wearable monitors have seen a tremendous increase in use over the past few years, replacing traditional Holter monitors.

News | Wearables | May 06, 2021
Wearable Cardiac Devices Market Will See Rapid Expansion in Coming Years
May 6, 2021 — The wearable cardiac devices market is set to grow from its current market was valued at more than $1.2...
read more
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.

Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor
SCAI 2021 Late-breaking Clinical Study Results
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from...
read more
The Bluegrass Vascular Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. 

The Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. 

News | EP Lab | May 06, 2021
Case Report on CRT Lead Placement in Obstructed Veins Using Surfacer System
May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility of...
read more
Videos | Cath Lab | May 05, 2021
VIDEO: Avoiding Higher Risk Cath Lab Patients May Not Improve Outcomes Scores
Ashwin Nathan M.D., a cardiology fellow in the division of Cardiovascular Medicine at the Hospital of the University of...
read more
The Corindus CorPath robotic cath lab navigation system allows operators to sit and control the procedure from behind a lead-lined booth, so they do not have to wear heavy aprons during the procedures.  Christoper Baker, M.D., Hoag Memorial Hospital using the system. #SCAI21 #SCAI2021

The Corindus CorPath robotic cath lab navigation system allows operators to sit and control the procedure from behind a lead-lined booth, so they do not have to wear heavy aprons during the procedures.  

Feature | Robotic Systems | May 05, 2021
Second Generation Robotic PCI System Performs Well Across Spectrum of Lesion Complexity
May 5, 2021 — A late-breaking study of the Siemens Healthineers Corindus Corpath GRX second-generation cath lab robotic...
read more
Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.

Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.

News | Cardiovascular Business | May 05, 2021
Avoiding High-risk Cath Lab Procedures Does Not Necessarily Improve Hospital Scores
May 5, 2021 — A late-breaking study presented at the Society for Cardiovascular Angiography and Interventions (SCAI)...
read more
A nurse checking an ECMO system being used to support a critically ill COVID-19 patient at Banner Health in Phoenix. ECMO can offer both hemodynamic support and oxygenation for COVID patients who otherwise cannot get enough pulmonary support from ventilators, or are in danger of organ failure.

A nurse checking an ECMO system being used to support a critically ill COVID-19 patient at Banner Health in Phoenix. ECMO can offer both hemodynamic support and oxygenation for COVID patients who otherwise cannot get enough pulmonary support from ventilators, or are in danger of organ failure.

News | ECMO Systems | May 04, 2021
Similar Long-Term Outcomes With and Without ECMO for Mechanically Ventilated COVID-19 Patients
May 4, 2021 – A new study, presented today at the 2021 American Association for Thoracic Surgery (AATS) 101st annual...
read more
© Copyright Wainscot Media. All Rights Reserved.